Search Results 781-790 of 17087 for treatment resistant depression
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy.
Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) · Overview · Participation eligibility · Participating Mayo ...
This especially includes medicines used to treat depression, including citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, olanzapine, paroxetine ...
Allen, M.D.. Psychiatrist. Rochester, MN. Areas of focus: Electroconvulsive therapy, Delirium, Neurocognitive disorder, Depression, Anxiety disorder, Bipolar ...
About this study. The purpose of this study is to see how well study drug works at treating people with fungal diseases that are refractory to or intolerant of ...
The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma. Print details. Share; Facebook · Twitter.
... resistant chronic lymphocytic leukemia. Patients ... Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since ...
Kids and screen time / transcranial magnetic stimulation therapy for depression / oral cancer reconstruction: Mayo Clinic Radio. As summer vacation rolls on ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.